Top menu


Helsinn Group grants exclusive licensing rights to MENARINI for Pracinostat

12/21/2018

mehr

Art in a click: MENARINI launches “Pills of Art”

10/25/2018

mehr

BERLIN-CHEMIE consistent with sustainability goals of United Nations

09/27/2018

mehr

MENARINI announces new governance

03/22/2018

mehr

MENARINI hires their 17.000th employee

03/12/2018

mehr

MENARINI increases number of members of the board - for the first time external members in majority

06/29/2017

mehr

Selvita and Menarini Group Announce Global License Agreement for Clinical Stage Oncology Drug PIM/FLT3 Inhibitor SEL24

03/28/2017

mehr

Menarini arrives in Columbia and Peru

03/15/2017

mehr

Menarini in Turkey: + 25% Growth in 2016 and New Headquarters in Istanbul

01/18/2017

mehr

Menarini acquires CELLSEARCH business from American group Janssen Diagnostics, pioneer in high-tech cancer diagnostics

12/20/2016

mehr

Menarini Group: 250 new employees in 10 months

12/02/2016

mehr

Chugai and Berlin-Chemie - the Menarini Group Announce Global License Agreement for an Anti-cancer Agent, PA799

11/28/2016

mehr

Paediatric network against ill- treatment of minors has grown beyond Italian borders.

10/18/2016

Tirana, 18th October 2016 – The project for a “Paediatric network against ill- treatment of minors”, launched and supported by the pharmaceutical company, Menarini, together with Telefono Azzurro, the Italian Federation of Paediatricians, and the Association of Italian Paediatric Hospitals, has grown beyond Italian borders.

mehr

Menarini launches a network of pediatricians against child abuse

05/27/2016

There are approx. 70-80 thousand children and adolescents in our country that suffer violence and physical, psychological and sexual abuse every year, but only a few cases come to light. To bring these "Suppressed" cases into the open and send a message of tangible assistance to these young, voicless victims, Menarini has launched the first project worldwide to create an anti-abuse network of 15 thousand "sentinel" pediatricians and general practitioners.

mehr

Menarini announces the founding of Vaxynethic, Joint venture with Biosynth

03/16/2016

The Menarini Group announces the founding of VaxYnethic, a joint venture between Menarini NewTech and BiosYnth, pioneer company operating in the field of technologies for the production of conjugated vaccines.

mehr

Search